IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Matrix Capital Management Company, LP

Q2 2025 Holdings

Filed 2025-08-14 | 4 holdings | $222.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Globalfoundries Inc(GFS)ORDINARY SHARESG39387108$132.7M3,475,00059.6%
Aura Biosciences Inc(AURA)COM05153U107$43.3M6,922,87019.5%
Maze Therapeutics Inc(MAZE)COM578784100$30.5M2,486,18413.7%
Zentalis Pharmaceuticals Inc(ZNTL)COM98943L107$16.2M13,959,9737.3%